IL165672A0 - Benzoic acid derivatives as modulators of prar alpha and gamma - Google Patents
Benzoic acid derivatives as modulators of prar alpha and gammaInfo
- Publication number
- IL165672A0 IL165672A0 IL16567204A IL16567204A IL165672A0 IL 165672 A0 IL165672 A0 IL 165672A0 IL 16567204 A IL16567204 A IL 16567204A IL 16567204 A IL16567204 A IL 16567204A IL 165672 A0 IL165672 A0 IL 165672A0
- Authority
- IL
- Israel
- Prior art keywords
- prar
- modulators
- gamma
- alpha
- benzoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201937A SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Therapeutic agents |
PCT/GB2003/002598 WO2004000295A1 (en) | 2002-06-20 | 2003-06-17 | Benzoic acid derivatives as modulators of ppar alpha and gamma |
Publications (1)
Publication Number | Publication Date |
---|---|
IL165672A0 true IL165672A0 (en) | 2006-01-15 |
Family
ID=20288295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16567204A IL165672A0 (en) | 2002-06-20 | 2004-12-09 | Benzoic acid derivatives as modulators of prar alpha and gamma |
Country Status (21)
Country | Link |
---|---|
US (1) | US7521461B2 (xx) |
EP (1) | EP1517680A1 (xx) |
JP (1) | JP4327085B2 (xx) |
KR (1) | KR20050014014A (xx) |
CN (1) | CN100400512C (xx) |
AR (1) | AR040332A1 (xx) |
AU (1) | AU2003240101B2 (xx) |
BR (1) | BR0311840A (xx) |
CA (1) | CA2490687A1 (xx) |
IL (1) | IL165672A0 (xx) |
IS (1) | IS7639A (xx) |
MX (1) | MXPA04012694A (xx) |
NO (1) | NO20045222L (xx) |
NZ (1) | NZ536972A (xx) |
PL (1) | PL375078A1 (xx) |
RU (1) | RU2339613C2 (xx) |
SE (1) | SE0201937D0 (xx) |
TW (1) | TW200403209A (xx) |
UA (1) | UA77527C2 (xx) |
WO (1) | WO2004000295A1 (xx) |
ZA (1) | ZA200409690B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
US7351858B2 (en) | 2002-06-20 | 2008-04-01 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
WO2004000790A1 (en) | 2002-06-20 | 2003-12-31 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
CN100482649C (zh) | 2003-09-17 | 2009-04-29 | 诺瓦提斯公司 | 有机化合物 |
CN101098690A (zh) * | 2004-12-06 | 2008-01-02 | 瑞莱恩特医药品有限公司 | 用于血脂治疗的ω-3脂肪酸和脂血异常剂 |
US7968574B2 (en) | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
DK1836169T5 (da) | 2004-12-28 | 2023-10-09 | Atnx Spv Llc | Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser |
US7816405B2 (en) * | 2005-04-19 | 2010-10-19 | Eisai R&D Management Co., Ltd. | Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
EP1940767A2 (en) * | 2005-09-07 | 2008-07-09 | Plexxikon, Inc. | Pparactive compounds |
JP2007234800A (ja) | 2006-02-28 | 2007-09-13 | Tdk Corp | 電子部品及びその製造方法 |
PL2514742T3 (pl) * | 2006-03-31 | 2015-07-31 | Univ Texas | Leki przeciwnowotworowe będące pochodnymi kwasu kawowego dostępnymi biologicznie po podaniu doustnym |
AU2007265373B2 (en) | 2006-06-29 | 2013-02-21 | Atnx Spv, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
AU2008240158B2 (en) | 2007-04-11 | 2014-07-10 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
CA2796419C (en) | 2010-04-16 | 2018-11-06 | Kinex Pharmaceuticals, Llc | Compositions and methods for the prevention and treatment of cancer |
EP2736329A4 (en) * | 2011-07-29 | 2015-03-25 | Tempero Pharmaceuticals Inc | COMPOUNDS AND METHODS |
HUE037637T2 (hu) | 2012-08-30 | 2018-09-28 | Athenex Inc | N-(3-fluorobenzil)-2-(5-(4-morfolinofenil)piridin-2-IL) acetamid, mint fehérje tirozin kináz modulátorok |
EP3719010B1 (en) * | 2017-11-30 | 2023-07-26 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Aromatic compound, pharmaceutical composition thereof and use thereof |
WO2022087634A1 (en) * | 2020-10-23 | 2022-04-28 | Nimbus Clotho, Inc. | Ctps1 inhibitors and uses thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK148576A (da) * | 1975-04-18 | 1976-10-19 | Boehringer Mannheim Gmbh | Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling |
DE2517229A1 (de) * | 1975-04-18 | 1976-10-28 | Boehringer Mannheim Gmbh | Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung |
US5334753A (en) * | 1992-03-12 | 1994-08-02 | Rhone-Poulenc Agriculture Ltd | Processes for preparing ortho-substituted benzoic acids |
DE19615263A1 (de) * | 1996-04-18 | 1997-10-23 | Bayer Ag | Benzyloxy-substituierte Phenylglycinolamide |
DE19616948C1 (de) | 1996-04-27 | 1997-11-27 | Wagner Gmbh J | Schneidwerkzeug, insbesondere Astschere |
JPH1072371A (ja) | 1996-08-28 | 1998-03-17 | Sankyo Co Ltd | 回腸型胆汁酸トランスポーター阻害剤 |
US5922767A (en) * | 1996-10-30 | 1999-07-13 | Ss Pharmaceutical Co., Ltd. | Substituted benzylurea derivatives and medicine containing the same |
KR20010024533A (ko) * | 1997-10-17 | 2001-03-26 | 오흘러 로스 제이. | 퀴놀린 유도체의 치료적 용도 |
WO1999032477A1 (en) | 1997-12-19 | 1999-07-01 | Schering Aktiengesellschaft | Ortho-anthranilamide derivatives as anti-coagulants |
SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
DE19825804C2 (de) | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
ES2287016T3 (es) | 1999-04-28 | 2007-12-16 | Sanofi-Aventis Deutschland Gmbh | Derivados de diaril-acido como ligandos del receptor ppar. |
IL145923A0 (en) | 1999-04-28 | 2002-07-25 | Aventis Pharma Gmbh | Tri-aryl acid derivatives as ppar receptor ligands |
JP4618845B2 (ja) | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体 |
GB9919411D0 (en) * | 1999-08-18 | 1999-10-20 | Zeneca Ltd | Chemical compounds |
US6509374B2 (en) * | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
-
2002
- 2002-06-20 SE SE0201937A patent/SE0201937D0/xx unknown
-
2003
- 2003-06-17 JP JP2004515010A patent/JP4327085B2/ja not_active Expired - Fee Related
- 2003-06-17 CA CA002490687A patent/CA2490687A1/en not_active Abandoned
- 2003-06-17 UA UA20041210011A patent/UA77527C2/uk unknown
- 2003-06-17 TW TW092116379A patent/TW200403209A/zh unknown
- 2003-06-17 EP EP03732715A patent/EP1517680A1/en not_active Withdrawn
- 2003-06-17 PL PL03375078A patent/PL375078A1/xx not_active Application Discontinuation
- 2003-06-17 MX MXPA04012694A patent/MXPA04012694A/es not_active Application Discontinuation
- 2003-06-17 WO PCT/GB2003/002598 patent/WO2004000295A1/en active Application Filing
- 2003-06-17 US US10/518,819 patent/US7521461B2/en not_active Expired - Fee Related
- 2003-06-17 CN CNB038143194A patent/CN100400512C/zh not_active Expired - Fee Related
- 2003-06-17 BR BR0311840-1A patent/BR0311840A/pt not_active IP Right Cessation
- 2003-06-17 RU RU2004135542/04A patent/RU2339613C2/ru not_active IP Right Cessation
- 2003-06-17 KR KR10-2004-7020684A patent/KR20050014014A/ko not_active Application Discontinuation
- 2003-06-17 AU AU2003240101A patent/AU2003240101B2/en not_active Ceased
- 2003-06-17 NZ NZ536972A patent/NZ536972A/en unknown
- 2003-06-20 AR ARP030102199A patent/AR040332A1/es not_active Application Discontinuation
-
2004
- 2004-11-29 NO NO20045222A patent/NO20045222L/no not_active Application Discontinuation
- 2004-11-30 ZA ZA200409690A patent/ZA200409690B/en unknown
- 2004-12-09 IL IL16567204A patent/IL165672A0/xx unknown
-
2005
- 2005-01-12 IS IS7639A patent/IS7639A/is unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004000295A1 (en) | 2003-12-31 |
UA77527C2 (en) | 2006-12-15 |
RU2004135542A (ru) | 2005-08-10 |
TW200403209A (en) | 2004-03-01 |
NZ536972A (en) | 2006-06-30 |
ZA200409690B (en) | 2005-10-11 |
NO20045222L (no) | 2005-01-19 |
PL375078A1 (en) | 2005-11-14 |
US20050267149A1 (en) | 2005-12-01 |
BR0311840A (pt) | 2005-03-15 |
RU2339613C2 (ru) | 2008-11-27 |
CN1662230A (zh) | 2005-08-31 |
MXPA04012694A (es) | 2005-03-23 |
AR040332A1 (es) | 2005-03-30 |
AU2003240101A1 (en) | 2004-01-06 |
IS7639A (is) | 2005-01-12 |
CN100400512C (zh) | 2008-07-09 |
JP4327085B2 (ja) | 2009-09-09 |
JP2006502105A (ja) | 2006-01-19 |
KR20050014014A (ko) | 2005-02-05 |
US7521461B2 (en) | 2009-04-21 |
CA2490687A1 (en) | 2003-12-31 |
EP1517680A1 (en) | 2005-03-30 |
AU2003240101B2 (en) | 2006-09-21 |
SE0201937D0 (sv) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL165672A0 (en) | Benzoic acid derivatives as modulators of prar alpha and gamma | |
NO20031777L (no) | Benzosyreisononylester og dens anvendelse | |
AU2003288902A8 (en) | Microcapsules and methods of use | |
DE60102137T2 (de) | Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren | |
PL375877A1 (en) | Hydantoine derivatives and their use as tace inhibitors | |
AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
IL179250A0 (en) | Stable crystal of 4-oxoquinoline compound and pharmaceutical compositions containing the same | |
PL373701A1 (en) | Substituted phenylacetamides and their use as glucokinase activators | |
AU2003265481A1 (en) | Microencapsulation of oxygen or water sensitive materials | |
NO20014409L (no) | Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase | |
EP1558341A4 (en) | TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE | |
PL372814A1 (en) | Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors | |
IL166108A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
DE50004965D1 (de) | Inhibitorkomposition zur Stabilisierung von radikalisch polymerisierbaren Substanzen | |
EP1691845A4 (en) | COMPOUNDS WITH MATRIX METALOPROTEINASE SUBSTRATES AND METHOD OF USE THEREOF | |
ZA200409361B (en) | Novel use of adenoviruses and nucleic acids coding therefore | |
AU2003239868A8 (en) | Sunscreen compositions and methods of use thereof | |
IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
TWI348385B (en) | Cosmetic composition containing ester of pentaerythritol and benzoic acid | |
AU2003230844A1 (en) | Crystals and structures of pak4kd kinase pak4kd | |
IL164267A0 (en) | Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase | |
AU2003203003A1 (en) | Sign and awning attachment system and method of use | |
AU2003206148A8 (en) | Nivalenol as specific inhibitor to transcriptional factor c-maf and pharmaceutical compositions comprising the same | |
AU2003221960A1 (en) | Indane acetic acid derivatives and their use as pharmaceutical agents | |
EP1666038A4 (en) | METHOD FOR STABILIZING A LIPID-RICH PLATE AND METHOD FOR PREVENTING THE BREAKAGE OF THE PLATE |